Patent 11919839 was granted and assigned to Valo Health on March, 2024 by the United States Patent and Trademark Office.
The present invention relates to inhibitors of histone deacetylases, in particular HDAC8, that are useful for the treatment of cancer and other diseases and disorders, as well as the synthesis and applications of said inhibitors.